News | Ultrasound Women's Health | January 15, 2016

Ultrasound Guidance Lowers Risks of Thoracic Nerve Block Technique for Mastectomy

Study finds use of ultrasound greatly reduces chances of puncturing lining of the lung, pneumothorax

ultrasound guidance, thoracic paravertebral nerve block, TPVB, mastectomy, Peter Stefanovich

January 15, 2016 — A regional anesthesia technique called thoracic paravertebral nerve block (TPVB) is highly effective in controlling pain after breast cancer surgery, but concern about potential complications may limit its use. A new study provides evidence that using ultrasound to guide the nerve blocking procedure lowers the risk of complications, reports a study in Anesthesia & Analgesia.

In particular, ultrasound-guided nerve blocking avoids potentially serious complications related to inadvertent puncture of the tissue lining the lungs (pleura), according to the report by Peter Stefanovich, M.D., and colleagues at Massachusetts General Hospital.

The researchers analyzed their experience with this nerve blocking in 856 women undergoing mastectomy from 2010 through 2013. In this procedure, a small amount of local anesthetic is injected around the thoracic nerve roots where they emerge from the spinal cord. This numbs the entire area of the chest, on one or both sides (if the nerves on both sides of the spinal cord are injected).

This regional nerve block provides excellent control of pain after breast cancer surgery. That's especially important because pain in the immediate postoperative period is a major risk factor for the development of chronic pain in women who have undergone mastectomy.

However, this nerve blocking isn't performed as often as it might be because of patient safety concerns—especially the risk of puncturing the pleura due to incorrect needle placement. This can lead to a serious complication called pneumothorax, where air enters the chest cavity, potentially causing collapse of the lung.

Stefanovich and colleagues analyzed their experience with ultrasound guidance to make this nerve blocking safer. Using ultrasound, the anesthesiologists performing nerve blocking were able to visualize the exact location of the thoracic spinal nerve roots. Ultrasound was used in addition to the conventional approach, using anatomical landmarks to guide the injection.

Following this procedure, anesthesiologists were able to confirm correct needle placement before injecting the local anesthetic. In the experience of more than 14,000 thoracic spinal nerve injections, there were no pleural punctures and no cases of pneumothorax.

Major complications related to this nerve blocking placement developed in six patients—a rate of 0.7 percent. Four patients had drops in blood pressure and heart rate, while two had suspected toxic effects of the local anesthetic used for the procedure.

Previous reports have suggested that performing this nerve block under ultrasound guidance might make the procedure safer. The new study is the first to provide evidence that ultrasound-guided nerve blocking lowers the risks of pleural puncture and pneumothorax.

"Avoidance of these complications may be a consequence of improved safety using real-time visualization and imaging of the pleura with ultrasound," Stefanovich and coauthors write. They hope their experience will encourage other hospitals to offer this highly effective regional anesthesia technique—potentially reducing the common and difficult-to-treat problem of chronic pain after mastectomy.

"Thoracic paravertebral nerve block is a technique that many consider to be high risk," commented Steven L. Shafer, M.D., of Stanford University, editor-in-chief of Anesthesia & Analgesia. "This study provides convincing evidence that, with ultrasound guidance and in experienced hands, TPVB is not a high-risk procedure."

For more information: www.iars.org

Related Content

Joseph J. Cappello Named Executive Director of Are You Dense Nonprofits
News | Breast Density | February 20, 2019
The boards of Are You Dense Inc. and Are You Dense Advocacy Inc., founded by the late Nancy M. Cappello, Ph.D.,...
Congress Directs FDA to Establish Federal Breast Density Inform Standard
News | Breast Density | February 19, 2019 | Jeff Zagoudis, Associate Editor
As part of a federal spending bill passed late Friday, Congress directed the U.S. Food and Drug Administration (FDA) to...
Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Fujifilm Exhibits Enterprise Imaging Solutions and Artificial Intelligence Initiative at HIMSS 2019
News | Enterprise Imaging | February 15, 2019
Fujifilm Medical Systems U.S.A. Inc. and Fujifilm SonoSite Inc. showcased their enterprise imaging and informatics...
Densitas Enters Partnership Agreement With TeleMammography Specialists
News | Breast Density | February 14, 2019
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography...
Hologic Launches Unifi Analytics Business Intelligence Tool
Technology | Analytics Software | February 12, 2019
Hologic Inc. announced the U.S. launch of Unifi Analytics, a business intelligence tool that allows healthcare...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
Mount Sinai's Digital 3-D Mammography Van Rolls Into New York City
News | Mammography | February 11, 2019
Mount Sinai Hospital recently launched the Mount Sinai Mobile Mammography Program (MMP), bringing essential breast...
breast density cancer awareness
News | Breast Density | February 08, 2019
Governor Michelle Lujan Grisham has signed breast density inform bill, ...
An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. 

Feature | Ultrasound Imaging | February 07, 2019 | Dave Fornell, Editor
Here is a list of six key trends in ul...